PE20070809A1 - Composicion veterinaria que comprende closantel - Google Patents

Composicion veterinaria que comprende closantel

Info

Publication number
PE20070809A1
PE20070809A1 PE2006001584A PE2006001584A PE20070809A1 PE 20070809 A1 PE20070809 A1 PE 20070809A1 PE 2006001584 A PE2006001584 A PE 2006001584A PE 2006001584 A PE2006001584 A PE 2006001584A PE 20070809 A1 PE20070809 A1 PE 20070809A1
Authority
PE
Peru
Prior art keywords
composition
composition including
closantel
veterinary composition
agent
Prior art date
Application number
PE2006001584A
Other languages
English (en)
Inventor
Alistair Couper
Mona Ferry
Lillian Cromie
Willy Blakely
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Publication of PE20070809A1 publication Critical patent/PE20070809A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A UNA COMPOSICION QUE COMPRENDE: A) UNA SALICILANILIDA TAL COMO CLOSANTEL QUE SE ENCUENTRA EN UNA CANTIDAD DE 1% A 30% P/V DE LA COMPOSICION; B) UN AGENTE ANTIPARASITICIDA TAL COMO BENCENOSULFONAMIDA O BENCIMIDAZOL; C) UN AGENTE DE AMPLIO ESPECTRO TAL COMO IVERMECTINA. DICHA COMPOSICION INHIBE LA CAPACIDAD REPRODUCTIVA DE ENDOPARASITOS EN DESARROLLO Y LA FORMA MADURA DE DICHOS PARASITOS TAL COMO FASCIOLA HEPATICA, HAEMONCHUS CONTORTUS, OESTRUS OVIS, ENTRE OTROS, SIENDO DE USO VETERINARIO
PE2006001584A 2005-12-09 2006-12-11 Composicion veterinaria que comprende closantel PE20070809A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0525093.1A GB0525093D0 (en) 2005-12-09 2005-12-09 Veterinary composition

Publications (1)

Publication Number Publication Date
PE20070809A1 true PE20070809A1 (es) 2007-08-27

Family

ID=35735821

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006001584A PE20070809A1 (es) 2005-12-09 2006-12-11 Composicion veterinaria que comprende closantel

Country Status (4)

Country Link
AR (1) AR058298A1 (es)
GB (2) GB0525093D0 (es)
PE (1) PE20070809A1 (es)
WO (1) WO2007066130A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2991173B1 (fr) * 2012-06-04 2015-11-06 Virbac Composition veterinaire a administration cutanee a base d'oxyclozanide
EA022327B1 (ru) * 2013-01-04 2015-12-30 Общество С Ограниченной Ответственностью "Рубикон" Инъекционное ветеринарное средство в форме раствора для борьбы с полиинвазиями животного и способ его получения
JP2017529393A (ja) 2014-09-12 2017-10-05 アンティバイオティクス エーピーエスＡｎｔｉｂｉｏｔｘ Ａｐｓ ハロゲン化サリチルアニリドの抗菌用途
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
GB201604484D0 (en) * 2016-03-16 2016-04-27 Antibiotx Aps And Københavns Uni University Of Copenhagen Topical antibacterial compositions
EP3403652A1 (en) * 2017-05-18 2018-11-21 Veterinärmedizinische Universität Wien Prevention and treatment of fibroblast growth factor 23 (fgf23)-associated disorders including chronic kidney disease (ckd)
IT201800004309A1 (it) * 2018-04-09 2019-10-09 Trattamenti topici per la miasi oculare
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA944191B (en) * 1993-06-15 1995-02-08 Univ Australian Synergistic anthelmintic compositions
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation

Also Published As

Publication number Publication date
GB0624565D0 (en) 2007-01-17
AR058298A1 (es) 2008-01-30
WO2007066130A3 (en) 2007-08-16
WO2007066130A2 (en) 2007-06-14
GB0525093D0 (en) 2006-01-18

Similar Documents

Publication Publication Date Title
PE20070809A1 (es) Composicion veterinaria que comprende closantel
GT200200114A (es) Champues con alcohol de behenilo
AR051102A1 (es) Composiciones para el tratamiento de la ropa.
ECSP045407A (es) Benzazoles sustituidos y el uso del mismo como inhibidores de quinasa raf
CL2019003798A1 (es) Métodos para tratar la enfermedad de huntington.
AR059456A1 (es) Agente benefico que comprende particulas de suministro
ECSP077299A (es) Nuevas composiciones farmacéuticas que comprenden ácido 4-(4-(3-(4-cloro-3-trifluorometil-fenil)-ureido)-3-fluoro-fenoxi)-piridin-2-carboxílico para el tratamiento de trastornos hiperproliferativos
NI200800060A (es) Bencimidazoles sustituidos como inhibidores de cinasa.
PE20030802A1 (es) Formas de dosificacion de liberacion inmediata que contienen dispersiones de farmaco solido
CL2010000234A1 (es) Combinacion fungicida que comprende fluoxaestrobin y al menos un imidazol seleccionado entre cyzofamid, prochloraz, triazoxide o pefurazoate y usos de la misma para combatir hongos fitopatogenos y en la obtencion de composiciones fungicidas que comprenden ademas agentes extendedores y/o surfactantes (divisional de 2673-2005)
CR9626A (es) Formas de dosificacion de liberacion retardada oral altamente biodisponible de un o-desmetilvenlafaxin succinato
CR7107A (es) Empleo de etoxilatos de alcoholes grasos como favorecedores de la penetracion
ECSP055575A (es) Uso de derivados de tio-oxindol en el tratamiento de enfermedades de la piel.
NI200800169A (es) Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento del dolor
AR109263A2 (es) Composición que comprende moxidectina
AR040205A1 (es) Composicion herbicida
GT200000141A (es) Material cementoso extruible.
BRPI0608287A2 (pt) agente endoparasiticida
HN2001000225A (es) Composicion blanqueante dental y procedimiento que emplea un agente blanqueante acido dicarboxilico
ECSP099611A (es) Composiciones farmaceuticas que comprenden un agente calcilitico
AR083329A1 (es) Composiciones para el cuidado oral
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
AR029092A1 (es) Composiciones para el tratamiento del cabello
CO2023018652A2 (es) Compuestos de triptamina fluorada, análogos de estos y métodos de uso de estos
UY29365A1 (es) Nueva forma de sal de un agonista de dopamina

Legal Events

Date Code Title Description
FA Abandonment or withdrawal